ARTC Pengajuan SEC - Arthrocare Corp- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

1005010

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Arthrocare Corp

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

February 10, 2015	SC 13G/A	ARTC / Arthrocare Corp / WESTFIELD CAPITAL MANAGEMENT CO LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* ArthroCare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) February 28, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
June 9, 2014	15-12B	- FORM 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-34607 ARTHROCARE CORPORATION (Exact name of registrant as specified in
June 4, 2014	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
June 4, 2014	EX-3.1	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ARTHROCARE CORPORATION Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ARTHROCARE CORPORATION 1. The name of the corporation is ArthroCare Corporation. 2. The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle, Delaware 19801. The name of its registered agent at such address is The Corporation Trust C
June 4, 2014	EX-3.2	AMENDED AND RESTATED BY-LAWS ARTHROCARE CORPORATION ARTICLE I. Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF ARTHROCARE CORPORATION ARTICLE I. OFFICES. SECTION l. Principal Office. The registered office of ArthroCare Corporation (the “Corporation”) in the State of Delaware shall be located in the City of Wilmington, County of New Castle, and the name of the registered agent in charge thereof shall be The CT Corporation System, Inc., or its representative. The p
June 2, 2014	SC 13D/A	ARTC / Arthrocare Corp / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) ArthroCare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Rec
June 2, 2014	SD	- SD SD 1 a2013conflictminerals.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT ArthroCare Corporation (Exact name of registrant as specified in its charter) 001-34607 (Commission File Number) Delaware 94-3180312 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 7000 W. William Cannon,
June 2, 2014	EX-1.01	ArthroCare Corporation Conflict Minerals Report For the Year Ended December 31, 2013 ArthroCare Corporation Conflict Minerals Report For the Year Ended December 31, 2013 This report for the year ended December 31, 2013 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934 (the Rule), pursuant to the specialized disclosure requirements of Form SD.
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT S-8 POS 1 a14-138171s8pos.htm POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-06297 REGISTRATION STATEMENT NO. 333-59379 REGISTRATION STATEMENT NO. 333-43296 REGISTRATION STATE
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT S-8 POS 1 a14-1381710s8pos.htm POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-06297 REGISTRATION STATEMENT NO. 333-59379 REGISTRATION STATEMENT NO. 333-43296 REGISTRATION STAT
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 29, 2014	SC 13D/A	ARTC / Arthrocare Corp / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ArthroCare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and C
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 29, 2014	RW	- REGISTRATION WITHDRAWAL REQUEST ArthroCare Corporation 7000 West William Cannon, Building One Austin, Texas 78735 May 29, 2014 VIA EDGAR U.
May 29, 2014	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
May 29, 2014	S-8 POS	- POST-EFFECTIVE AMENDMENT TO A S-8 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on May 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 21, 2014	8-K	Other Events 8-K 1 a14-1331718k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 9
May 8, 2014	8-K	Submission of Matters to a Vote of Security Holders 8-K 1 a14-1231818k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 94
May 2, 2014	10-Q	Quarterly Report - 10-Q 10-Q 1 artc2014q110-q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:
May 2, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 q12014earningsrelease.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0
May 2, 2014	EX-99.1	Financial Tables Appended ARTHROCARE CORPORATION Condensed Consolidated Balance Sheets - Unaudited (in thousands, except par value data) March 31, 2014 December 31, 2013 ASSETS Current assets: Cash and cash equivalents $ 191,004 $ 214,853 Accounts re EX-99.1 2 q12014earningsrelease991.htm EXHIBIT FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS Austin, Texas - May 2, 2014 - ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended March 31, 2014. FIRST QU
April 30, 2014	10-K/A	Annual Report - 10-K/A 10-K/A 1 a2013form10-ka.htm 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Commission File Number: 001-34607 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware State or other
April 10, 2014	DEFA14A	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide
April 10, 2014	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
April 3, 2014	DEFM14A	- DEFM14A Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 28, 2014	DEFA14A	- DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide
March 28, 2014	DEFA14A	- DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide
March 14, 2014	DEFA14A	- CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 94-3180312 (State or Other Jurisdiction of (Commission File Number) (I.
March 14, 2014	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 94-3180312 (State or Other Jurisdiction of (Commission File Number) (I.
March 10, 2014	SC 13G/A	ARTC / Arthrocare Corp / WESTFIELD CAPITAL MANAGEMENT CO LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* ArthroCare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) February 28, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
March 6, 2014	PREM14A	- PREM14A Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 14, 2014	SC 13G/A	ARTC / Arthrocare Corp / SAC Capital Advisors LP - AMENDMENT NO. 2 Passive Investment SC 13G/A 1 a11286021.htm AMENDMENT NO. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ARTHROCARE CORPORATION (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 043136100 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Ch
February 14, 2014	SC 13G/A	ARTC / Arthrocare Corp / HealthCor Management, L.P. - AMENDMENT TO SCHEDULE 13G Passive Investment SECURITIES & EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No.2)* Arthrocare Corp. (Name of Issuer) Common Stock, $.001 Par Value Per Share (Title of Class of Securities) 043136100 (CUSIP Number) December 31, 2013 (Date of Ev
February 13, 2014	EX-2.31	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-06297, 333-43296, 333-56284, 333-59379, 333-62130, 333-105140, 333-106409, 333-120932, 333-135399, 333-151488, 333-170308) and Form S-3 (No. 166789) of ArthroCare Corporation of our report dated February 13, 2014 relating to
February 13, 2014	EX-9.91	FORWARD-LOOKING STATEMENTS Exhibit 99.1 FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K for the year ended December 31, 2013 contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors, the news media and others. Forward-looking statements often incl
February 13, 2014	10-K	Annual Report - 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Commission File Number: 001-34607 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware State or other jurisdiction of Incorporation or or
February 13, 2014	EX-2.11	SUBSIDIARIES OF THE REGISTRANT Subsidiary State or Country of Incorporation or Organization ArthroCare (Australasia) Pty Ltd. Australia ArthroCare (Deutschland) AG Germany ArthroCare (Hong Kong) Limited Hong Kong ArthroCare Canada Limited Canada Arth Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Subsidiary State or Country of Incorporation or Organization ArthroCare (Australasia) Pty Ltd. Australia ArthroCare (Deutschland) AG Germany ArthroCare (Hong Kong) Limited Hong Kong ArthroCare Canada Limited Canada ArthroCare Corporation Cayman Islands Cayman Islands ArthroCare Costa Rica, S.R.L. Costa Rica ArthroCare Europe AB Sweden ArthroCare France s
February 13, 2014	SC 13D/A	ARTC / Arthrocare Corp / OEP AC Holdings, LLC - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* ArthroCare Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 0-027422 (Commission File Number) OEP AC Holdings, LLC 320 Park Avenue, 18th Floor New York, NY 10022 (212) 277-1500 Copy to: Derek M. Winokur
February 13, 2014	EX-99.1	ARTHROCARE REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS Austin, Texas - February 13, 2014 - ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended and year ended December 31, 2013. FOURTH QUARTER 2
February 13, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 q42013earningsrelease.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporat
February 13, 2014	EX-3.3	CERTIFICATE OF AMENDMENT CERTIFICATE OF DESIGNATIONS OF SERIES A 3.00% CONVERTIBLE PREFERRED STOCK OF ARTHROCARE CORPORATION FILED IN THE OFFICE OF THE SECRETARY OF STATE OF THE STATE OF DELAWARE ON SEPTEMBER 1, 2009 Exhibit 3.3 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF DESIGNATIONS OF SERIES A 3.00% CONVERTIBLE PREFERRED STOCK OF ARTHROCARE CORPORATION FILED IN THE OFFICE OF THE SECRETARY OF STATE OF THE STATE OF DELAWARE ON SEPTEMBER 1, 2009 ArthroCare Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY THAT: FIRST: A Certificate
February 13, 2014	EX-3.22	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of ArthroCare Corporation (the "Company") hereby certifies, to such officer's knowledge, that: 1. The accompanying annual report on Form 10-K of th
February 13, 2014	EX-3.12	CERTIFICATION PURSUANT TO RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 31.2 CERTIFICATION PURSUANT TO RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Todd Newton, certify that: 1. I have reviewed this annual report on Form 10-K of ArthroCare Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
February 13, 2014	EX-3.21	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of ArthroCare Corporation (the "Company") hereby certifies, to such officer's knowledge, that: 1. The accompanying annual report on Form 10-K of th
February 13, 2014	EX-1	VOTING AGREEMENT Exhibit 1 VOTING AGREEMENT VOTING AGREEMENT, dated as of February 2, 2014 (this “Agreement”), by and among Smith & Nephew, Inc.
February 13, 2014	EX-3.11	CERTIFICATION PURSUANT TO RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 31.1 CERTIFICATION PURSUANT TO RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, David Fitzgerald, certify that: 1. I have reviewed this annual report on Form 10-K of ArthroCare Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
February 12, 2014	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the undersigned hereby agree to (i) the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, $0.001 par value per share, of ArthroCare Corporation. and (ii) that this Joint
February 12, 2014	DEFA14A	- DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide
February 12, 2014	SC 13D	ARTC / Arthrocare Corp / SMITH & NEPHEW PLC - FORM SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ARTHROCARE CORPORATION (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 043136100 (CUSIP Number) John W. Campo, Jr., Esq. Chief Legal Officer Smith & Nephew, Inc. 150 Minuteman Road Andover, MA 01810 Tel. No.: (978) 749-1000 (Name, A
February 11, 2014	SC 13G/A	ARTC / Arthrocare Corp / VANGUARD GROUP INC Passive Investment SC 13G/A 1 arthrocarecorp.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: ArthroCare Corp Title of Class of Securities: Common Stock CUSIP Number: 043136100 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to designate the rule pursuant to whic
February 3, 2014	8-K/A	Entry into a Material Definitive Agreement, Financial Statements and Exhibits - AMENDMENT TO FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A (Amendment No.
February 3, 2014	EX-99.2	VOTING AGREEMENT Exhibit 99.2 VOTING AGREEMENT VOTING AGREEMENT, dated as of February 2, 2014 (this “Agreement”), by and among Smith & Nephew, Inc., a Delaware corporation (“Parent”), and the Person listed on Schedule 1 hereto (“Stockholder”). W I T N E S S E T H: WHEREAS, concurrently with the execution of this Agreement, ArthroCare Corporation, a Delaware corporation (the “Company”), Parent, and Rosebud Acquisit
February 3, 2014	EX-2.1	AGREEMENT AND PLAN OF MERGER dated as of February 2, 2014 ARTHROCARE CORPORATION, SMITH & NEPHEW, INC. ROSEBUD ACQUISITION CORPORATION SMITH & NEPHEW PLC Exhibit 2.1 EXPLANATORY NOTE TO THIS EXHIBIT The representations and warranties included in this Agreement and Plan of Merger (the “Merger Agreement”) were made by the parties to the Merger Agreement for their respective contractual benefit. These representations and warranties are made as of specific dates, only for purposes of the Merger Agreement and for the benefit of the parties thereto. Thes
February 3, 2014	8-K	Entry into a Material Definitive Agreement - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 0-027422 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
February 3, 2014	EX-99.1	VOTING AGREEMENT Exhibit 99.1 VOTING AGREEMENT VOTING AGREEMENT, dated as of February 2, 2014 (this “Agreement”), by and among Smith & Nephew, Inc., a Delaware corporation (“Parent”), and each of the Persons listed on Schedule 1 hereto (each a “Stockholder” and collectively, the “Stockholders”). W I T N E S S E T H: WHEREAS, concurrently with the execution of this Agreement, ArthroCare Corporation, a Delaware corp
February 3, 2014	EX-2.1	AGREEMENT AND PLAN OF MERGER dated as of February 2, 2014 ARTHROCARE CORPORATION, SMITH & NEPHEW, INC. ROSEBUD ACQUISITION CORPORATION SMITH & NEPHEW PLC Exhibit 2.1 EXPLANATORY NOTE TO THIS EXHIBIT The representations and warranties included in this Agreement and Plan of Merger (the “Merger Agreement”) were made by the parties to the Merger Agreement for their respective contractual benefit. These representations and warranties are made as of specific dates, only for purposes of the Merger Agreement and for the benefit of the parties thereto. Thes
February 3, 2014	EX-99.2	VOTING AGREEMENT Exhibit 99.2 VOTING AGREEMENT VOTING AGREEMENT, dated as of February 2, 2014 (this “Agreement”), by and among Smith & Nephew, Inc., a Delaware corporation (“Parent”), and the Person listed on Schedule 1 hereto (“Stockholder”). W I T N E S S E T H: WHEREAS, concurrently with the execution of this Agreement, ArthroCare Corporation, a Delaware corporation (the “Company”), Parent, and Rosebud Acquisit
February 3, 2014	DEFA14A	- CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 0-027422 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
February 3, 2014	DEFA14A	- DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide
February 3, 2014	EX-99.1	VOTING AGREEMENT Exhibit 99.1 VOTING AGREEMENT VOTING AGREEMENT, dated as of February 2, 2014 (this “Agreement”), by and among Smith & Nephew, Inc., a Delaware corporation (“Parent”), and each of the Persons listed on Schedule 1 hereto (each a “Stockholder” and collectively, the “Stockholders”). W I T N E S S E T H: WHEREAS, concurrently with the execution of this Agreement, ArthroCare Corporation, a Delaware corp
February 3, 2014	DEFA14A	- AMENDMENT TO FORM 8-K DEFA14A 1 a14-476228ka.htm AMENDMENT TO FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 0-027422 94-3180
January 21, 2014	8-K	Other Events - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2014 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34607 94-3180312 (State or other jurisdiction of Incorporation) (Commission
January 7, 2014	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 0-027422 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
January 7, 2014	EX-99.1	ArthroCare Announces entry into a Deferred Prosecution Agreement Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ArthroCare Announces entry into a Deferred Prosecution Agreement ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, and the U.S. Department of Justice (“DOJ”), entered into a Deferred Prosecution Agreement (“DPA”) filed today with the United States
January 7, 2014	EX-10.1	UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS AUSTIN DIVISION Exhibit 10.1 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS AUSTIN DIVISION UNITED STATES OF AMERICA ) ) Plaintiff, ) ) v. ) CRIMINAL NO. ) ARTHROCARE CORPORATION, ) ) Defendant. ) DEFERRED PROSECUTION AGREEMENT Defendant ArthroCare Corporation (the “Company”), by its undersigned representatives, pursuant to authority granted by the Company’s Board of Directors, and the United States Depar
December 13, 2013	8-K	Submission of Matters to a Vote of Security Holders - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File Number) (I.R
November 7, 2013	SC 13G/A	ARTC / Arthrocare Corp / WESTFIELD CAPITAL MANAGEMENT CO LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ArthroCare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) October 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S
October 29, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 q32013earningsrelease.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporati
October 29, 2013	EX-99.1	Financial Tables Appended ARTHROCARE CORPORATION Condensed Consolidated Balance Sheets - Unaudited (in thousands, except par value data) September 30, 2013 December 31, 2012 ASSETS Current assets: Cash and cash equivalents $ 208,435 $ 218,787 Account FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS Austin, Texas - October 29, 2013 - ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended September 30, 2013. THIRD QUARTER 2013 SUMMARY •Total revenue of $
October 29, 2013	10-Q	Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3460
October 23, 2013	DEF 14A	- DEFINITIVE PROXY STATEMENT DEF 14A 1 a13-219991def14a.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check th
October 9, 2013	PRE 14A	- PRELIMINARY PROXY NOT RELATED TO A CONTESTED MATTER OR MERGER/ACQUISITION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confide
September 9, 2013	8-K	Regulation FD Disclosure 8-K 1 a13-2041218k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware
September 5, 2013	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34607 94-3180312 (State or other jurisdiction of Incorporation) (Commission
August 5, 2013	EX-99.1	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2013 ARTHROCARE CORPORA UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 001-34607 (Commission File Number)
August 5, 2013	8-K	- 8-K FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS SECOND QUARTER 2013 FINANCIAL RESULTS Austin, Texas - August 5, 2013 - ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended June 30, 2013. SECOND QUARTER 2013 SUMMARY •Total revenue of $92.1
August 5, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 o TRANSITION REPORT PURSUANT TO S Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34607 Art
July 22, 2013	8-K	Other Events 8-K 1 a13-1697618k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607
July 2, 2013	EX-2.1	AGREEMENT AND PLAN OF MERGER by and among ARTHROCARE CORPORATION, as Purchaser, DURANTE MERGER SUB, INC., as the Merger Sub, ENTRIGUE SURGICAL, INC., as the Company, SHAREHOLDER REPRESENTATIVE SERVICES LLC, as the Representative July 1, 2013 Exhibit 2.1 Execution Copy AGREEMENT AND PLAN OF MERGER by and among ARTHROCARE CORPORATION, as Purchaser, DURANTE MERGER SUB, INC., as the Merger Sub, ENTRIGUE SURGICAL, INC., as the Company, and SHAREHOLDER REPRESENTATIVE SERVICES LLC, as the Representative July 1, 2013 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 Section 1.1 Defined Terms 2 ARTICLE II THE MERGER 15 Section 2.1 Effects of the
July 2, 2013	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events 8-K 1 a13-1599018k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 0-027422 94
July 2, 2013	EX-99.1	ArthroCare Announces Acquisition of ENTrigue Surgical, Inc. Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ArthroCare Announces Acquisition of ENTrigue Surgical, Inc. AUSTIN, Texas—(BUSINESS WIRE) — July 2, 2013 — ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, today announced that it has completed the acquisition of ENTrigue Surgical, Inc., a private
June 28, 2013	8-K	Other Events 8-K 1 a13-1590518k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 0-027422 9
May 24, 2013	8-K	Submission of Matters to a Vote of Security Holders - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File Number) (I.R.S. E
May 7, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number) 94-
May 7, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 o TRANSITION REPORT PURSUANT TO Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arth
May 7, 2013	EX-99.1	ARTHROCARE REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS Austin, Texas — May 7, 2013 — ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2013. FIRST QUARTER 2013 SUMMARY · Total r
May 6, 2013	SC 13G/A	ARTC / Arthrocare Corp / WESTFIELD CAPITAL MANAGEMENT CO LP - AMENDMENT NO. 3 Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 3) Under the Securities Exchange Act of 1934 ArthroCare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) April 30, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed
April 1, 2013	DEF 14A	- DEF 14A QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 29, 2013	8-K	Other Events - ARTHROCARE CORPORATION 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission Fi
March 8, 2013	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
March 8, 2013	EX-10.1	2013 Annual Bonus Plan Executive Officers Exhibit 10.1 2013 Annual Bonus Plan Executive Officers Objective: · Align the interests of executive officers and shareholders in the future growth and success of ArthroCare Corporation (the “Company”) by rewarding executive officer performance. Bonus Potential: · An Eligible Participant’s (defined below) Target Bonus Potential is defined as a percentage of each such Eligible Participant’s annual
March 1, 2013	8-K	Regulation FD Disclosure - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34607 94-3180312 (State or other jurisdiction of Incorporation) (Commissio
February 28, 2013	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 001-34607 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
February 14, 2013	EX-21.1	SUBSIDIARIES OF THE REGISTRANT QuickLinks - Click here to rapidly navigate through this document Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Subsidiary State or Country of Incorporation or Organization ArthroCare (Australasia) Pty Ltd. Australia ArthroCare (Deutschland) AG Germany ArthroCare (Hong Kong) Limited Hong Kong ArthroCare Canada Limited Canada ArthroCare Corporation Cayman Islands Cayman Islands ArthroCare Costa Rica,
February 14, 2013	EX-99.1	ARTHROCARE REPORTS FOURTH QUARTER AND FULL YEAR 2012 FINANCIAL RESULTS Exhibit 99.1 CONTACTS: FOR IMMEDIATE RELEASE: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS FOURTH QUARTER AND FULL YEAR 2012 FINANCIAL RESULTS Austin, Texas — February 13, 2012 — ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2012. FO
February 14, 2013	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission File Number: 0-27422 ARTHROC Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission File Number: 0-27422 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware State or other jurisdiction of Incorporation or orga
February 14, 2013	EX-99.1	FORWARD-LOOKING STATEMENTS QuickLinks - Click here to rapidly navigate through this document Exhibit 99.1 FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K for the year ended December 31, 2012 contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors
February 14, 2013	EX-99.1	JOINT FILING AGREEMENT EX-99.1 2 s9081781b.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf
February 14, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a13-514218k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (
February 14, 2013	SC 13G/A	ARTC / Arthrocare Corp / SAC Capital Advisors LP - AMENDMENT #1 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ARTHROCARE CORPORATION (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 043136100 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the
February 11, 2013	SC 13G/A	ARTC / Arthrocare Corp / VANGUARD GROUP INC Passive Investment arthrocarecorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: ArthroCare Corp Title of Class of Securities: Common Stock CUSIP Number: 043136100 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to de
February 8, 2013	SC 13G/A	ARTC / Arthrocare Corp / WESTFIELD CAPITAL MANAGEMENT CO LP - AMENDMENT NO. 2 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Arthrocare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
January 30, 2013	8-K	Other Events - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 0-027422 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
January 23, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2013 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File Number) (IRS
January 4, 2013	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in charter) Delaware 0-027422 94-3180312 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
December 12, 2012	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
November 30, 2012	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessi
November 30, 2012	SC 13G	ARTC / Arthrocare Corp / SAC Capital Advisors LP Passive Investment SC 13G 1 a8720847a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ARTHROCARE CORPORATION. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 043136100 (CUSIP Number) November 29, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriat
November 13, 2012	8-K	Regulation FD Disclosure - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
October 31, 2012	EX-10.1	AMENDMENT TO JUNE 28, 2000 LICENSE AGREEMENT AND SETTLEMENT AGREEMENT Exhibit 10.1 AMENDMENT TO JUNE 28, 2000 LICENSE AGREEMENT AND SETTLEMENT AGREEMENT This Amendment (?the Amendment?) to the June 28, 2000 License Agreement (?License Agreement?) dated and effective as of the 30th day of July, 2012 (?Amendment Effective Date?) and Settlement Agreement, is by and between the following parties: a) Stryker Corporation, a corporation organized under the laws of the Stat
October 31, 2012	EX-99.1	ARTHROCARE REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS Exhibit 99.1 CONTACTS: FOR IMMEDIATE RELEASE: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS Austin, Texas — October 31, 2012 — ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the third quarter ended September 30, 2012. THIRD QUARTER 2012 HIGHLIGH
October 31, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422
October 31, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
September 7, 2012	8-K	Regulation FD Disclosure - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Numbe
August 27, 2012	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 24, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission F
August 1, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number)
August 1, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arthr
August 1, 2012	EX-99.1	ARTHROCARE REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS Austin, Texas — August 1, 2012 — ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the second quarter ended June 30, 2012. SECOND QUARTER 2012 HIGHLIGHTS ·
June 5, 2012	8-K	Financial Statements and Exhibits, Other Events - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number) 94
June 5, 2012	EX-99.1	Case 1:08-cv-00574-SS Document 320 Filed 06/04/12 Page 1 of 7 Exhibit 99.1 Case 1:08-cv-00574-SS Document 320 Filed 06/04/12 Page 1 of 7 FILED 2012 JUN -4 PM 2: 58 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS CLERK US DISTRICT COURT AUSTIN DIVISION WESTERN DISTRICT OF TEXAS BY DEPUTY \| \| Civil Action IN RE ARTHROCARE CORPORATION \| No. 1:08-cv-00574-SS SECURITIES LITIGATION \| \| CLASS ACTION \| FINAL JUDGMENT AND ORDER OF DISMISSAL OF THE LITIGATION W
May 29, 2012	8-K	Regulation FD Disclosure, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission File
May 2, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File Number) (I.R.S. Em
May 2, 2012	EX-99.1	ARTHROCARE REPORTS FIRST QUARTER 2012 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS FIRST QUARTER 2012 FINANCIAL RESULTS Austin, Texas — May 2, 2012 — ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012. FIRST QUARTER 2012 HIGHLIGHTS · Tota
May 2, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arth
April 3, 2012	DEF 14A	- DEF 14A QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 27, 2012	SC 13G/A	ARTC / Arthrocare Corp / WESTFIELD CAPITAL MANAGEMENT CO LP - AMENDMENT NO. 1 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Arthrocare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
March 2, 2012	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34607 94-3180312 (State or other jurisdiction of Incorporation) (Commissio
March 2, 2012	EX-10.1	2012 Executive Officer Bonus Plan Exhibit 10.1 2012 Executive Officer Bonus Plan Objective: · Align the interests of employees and shareholders in the future growth and success of ArthroCare Corporation (the “Company”) by rewarding employee performance. Bonus Pool: · The officer bonus pool is equal to the sum of the target bonuses of all officers in the pool and who are covered by this document during the period of January 1, 2012
February 16, 2012	EX-99.1	ARTHROCARE REPORTS FOURTH QUARTER AND FULL YEAR 2011 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Misty Romines 512-391-3902 ARTHROCARE REPORTS FOURTH QUARTER AND FULL YEAR 2011 FINANCIAL RESULTS Austin, Texas — February 16, 2012 — ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2011, as
February 16, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34607 94-3180312 (State or other jurisdiction of Incorporation) (Commissio
February 16, 2012	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Commission File Number: 0-27422 ARTHROC 10-K 1 a12-1345110k.htm ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Commission File Number: 0-27422 ARTHROCARE CORPORATION (Exact name of registrant as specified in its
February 16, 2012	EX-99.1	FORWARD-LOOKING STATEMENTS Exhibit 99.1 FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K for the year ended December 31, 2011 contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors, the news media and others. Forward-looking statements often incl
February 16, 2012	EX-21.1	SUBSIDIARIES OF THE REGISTRANT Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Subsidiary State or Country of Incorporation or Organization ArthroCare (Australasia) Pty Ltd. f/k/a TiMax Surgical Pty Ltd. Australia ArthroCare (Deutschland) AG f/k/a ArthroCare (Deutschland) GmbH Germany ArthroCare (Hong Kong) Limited Hong Kong ARTHROCARE CANADA LIMITED Canada ArthroCare Corporation Cayman Islands Cayman Islands ArthroCare Costa Rica,
February 13, 2012	SC 13G	ARTC / Arthrocare Corp / WESTFIELD CAPITAL MANAGEMENT CO LP - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Arthrocare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 043136100 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S
February 8, 2012	SC 13G	ARTC / Arthrocare Corp / VANGUARD GROUP INC Passive Investment arthrocarecorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:0 )* Name of issuer: Arthrocare Corp Title of Class of Securities: Common Stock CUSIP Number: 043136100 Date of Event Which Requires Filing of this Statement: December 31, 2011 Check the appropriate box to des
January 20, 2012	EX-10.1	SECOND AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.1 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT This Second Amendment to Employment Agreement (the “Amendment”) is entered into as of January 20, 2012 (the “Effective Date”), between Todd Newton (“Executive”) and ArthroCare Corporation, a Delaware corporation (the “Company”). RECITALS WHEREAS, on April 2, 2009, Executive and the Company entered into an Employment Agreement, as amended Decemb
January 20, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34607 94-3180312 (State or other jurisdiction (Commission File Number) (I.R
January 11, 2012	EX-10.1	ARTHROCARE CORPORATION LONG TERM INCENTIVE PROGRAM (Effective January 6, 2012) ARTICLE I Exhibit 10.1 ARTHROCARE CORPORATION LONG TERM INCENTIVE PROGRAM (Effective January 6, 2012) ARTICLE I PURPOSE The purpose of this document is to set forth the general terms and conditions applicable to the ArthroCare Corporation Long Term Incentive Program (the ?Program?) established by the Compensation Committee of the Board of Directors of ArthroCare Corporation (the ?Company?) pursuant to, and
January 11, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 a12-255018k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2012 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 001
January 11, 2012	EX-10.2	Grant Agreement for Performance Shares for Senior Executives under the ArthroCare Corporation Long Term Incentive Program and ArthroCare Corporation Amended and Restated 2003 Incentive Stock Plan Exhibit 10.2 Grant Agreement for Performance Shares for Senior Executives under the ArthroCare Corporation Long Term Incentive Program and ArthroCare Corporation Amended and Restated 2003 Incentive Stock Plan This is a Grant Agreement between ArthroCare Corporation (the ?Company?) and the individual (the ?Holder?) named in the Notice of Grant of Performance Shares (the ?Notice?) attached hereto as
December 6, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2011 ARTHROCARE CORPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
December 2, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2011 ARTHROCARE CORPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
November 28, 2011	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Numbe
November 28, 2011	EX-99.1	ArthroCare Announces Agreement in Principle to Settle Securities Class Action Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 ArthroCare Announces Agreement in Principle to Settle Securities Class Action AUSTIN, Texas?(BUSINESS WIRE)?November 28, 2011 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced that it has reached an agreement in principle to settle the
November 2, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2011 ARTHROCARE CORPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
November 2, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 OR o TRANSITION REPORT PURSU Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422
November 2, 2011	EX-99.1	ARTHROCARE REPORTS THIRD QUARTER 2011 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 ARTHROCARE REPORTS THIRD QUARTER 2011 FINANCIAL RESULTS Austin, Texas ? November 2, 2011 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the third quarter ended September 30, 2011. REVENUE Total revenue from
October 24, 2011	EX-99.1	IN THE UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS AUSTIN DIVISION Exhibit 99.1 IN THE UNITED STATES DISTRICT COURT WESTERN DISTRICT OF TEXAS AUSTIN DIVISION NICOLAS WEIL, Derivatively on Behalf Of Nominal Defendant ARTHROCARE CORPORATION, Plaintiff, CASE NO.: 08-CA-787-SS v. MICHAEL A. BAKER, BARBARA D. BOYAN, TORD B. LENDAU, TERRENCE E. GEREMSKI, PETER L. WILSON, JAMES G. FOSTER and DAVID F. FITZGERALD, Defendants. And ARTHROCARE CORPORATION, Nominal Defendant.
October 24, 2011	EX-99.2	IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS AUSTIN DIVISION Exhibit 99.2 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS AUSTIN DIVISION NICHOLAS WEIL, Derivatively on Behalf Of Nominal Defendant ARTHROCARE CORPORATION, Plaintiff, CASE NO.: 08-CA-00787-SS v. MICHAEL A. BAKER, BARBARA D. BOYAN, TORD B. LENDAU, TERRENCE E. GEREMSKI, PETER L. WILSON, JAMES G. FOSTER and DAVID F. FITZGERALD, Defendants, and ARTHROCARE CORPORATION, Nominal
October 24, 2011	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-27422 (Commission File Number)
August 3, 2011	EX-99.1	ARTHROCARE REPORTS SECOND QUARTER 2011 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 ARTHROCARE REPORTS SECOND QUARTER 2011 FINANCIAL RESULTS Austin, Texas ? August 3, 2011 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the second quarter ended June 30, 2011 as follows: SECOND QUARTER 2011 H
August 3, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arthr
August 3, 2011	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission Fi
July 1, 2011	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File Number) (I.R.S.
June 2, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2011 ARTHROCARE CORPORATI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission File
May 24, 2011	8-K	Regulation FD Disclosure 8-K 1 a11-1312418k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027
May 16, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2011 ARTHROCARE CORPORATI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File Number) (I.R.S. E
May 16, 2011	EX-99.	EX-99. Exhibit 99 Form 4 Joint Filer Information Date of Event Requiring Statement: May 12, 2011 Issuer Name and Ticker or Trading Symbol: ArthroCare Corporation, ARTC Designated Filer: OEP AC Holdings, LLC Other Joint Filers: One Equity Partners III, L.
May 2, 2011	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission File
May 2, 2011	EX-10.43	OFFICE LEASE 7000 WEST AT LANTANA BUILDINGS 1 & 2 7000 WEST WILLIAM CANNON DRIVE AUSTIN, TEXAS CARRAMERICA LANTANA, LP, as Landlord, ARTHROCARE CORPORATION, as Tenant. Ehibit 10.43 OFFICE LEASE 7000 WEST AT LANTANA BUILDINGS 1 & 2 7000 WEST WILLIAM CANNON DRIVE AUSTIN, TEXAS CARRAMERICA LANTANA, LP, as Landlord, and ARTHROCARE CORPORATION, as Tenant. TABLE OF CONTENTS Page ARTICLE 1 PREMISES, BUILDING, PROJECT, AND COMMON AREAS 4 ARTICLE 2 LEASE TERM 5 ARTICLE 3 BASE RENT 6 ARTICLE 4 ADDITIONAL RENT 6 ARTICLE 5 USE OF PREMISES 11 ARTICLE 6 SERVICES AND UTILITIES
May 2, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arth
May 2, 2011	EX-99.1	ARTHROCARE REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 ARTHROCARE REPORTS FIRST QUARTER 2011 FINANCIAL RESULTS Austin, Texas ? May 2, 2011 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2011 as follows: FIRST QUARTER 2011 HIGHLI
April 25, 2011	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 25, 2011 (April 20, 2011) ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File
April 6, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2011 ARTHROCARE CORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission Fil
March 24, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2011 ARTHROCARE CORPORA UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission Fi
March 24, 2011	EX-10.1	2011 Executive Officer Bonus Plan Exhibit 10.1 2011 Executive Officer Bonus Plan Objective: ? Align the interests of employees and shareholders in the future growth and success of ArthroCare Corporation (the ?Company?) by rewarding employee performance. Bonus Pool: ? The officer bonus pool is equal to the sum of the target bonuses of all officers in the pool and are covered in this document during the period of January 1, 2011 thr
March 23, 2011	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 2, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2011 ARTHROCARE CORPORAT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number) 9
February 14, 2011	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 Commission File Number: 0-27422 ARTHROC Use these links to rapidly review the document TABLE OF CONTENTS ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 Commission File Number: 0-27422 ARTHROCARE CORPORATION
February 14, 2011	EX-99.1	ARTHROCARE REPORTS FOURTH QUARTER AND FULL YEAR 2010 FINANCIAL RESULTS EXHIBIT 99.1 FOR IMMEDIATE RELEASE: CONTACTS: Corinne Ervin 512-391-3907 The Ruth Group Nick Laudico / Zack Kubow 646-536-7030 / 7020 ARTHROCARE REPORTS FOURTH QUARTER AND FULL YEAR 2010 FINANCIAL RESULTS Austin, Texas ? February 14, 2011 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth
February 14, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2011 ARTHROCARE CORP UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Numbe
February 14, 2011	EX-10.42	GENERAL RELEASE AND SEPARATION AGREEMENT QuickLinks - Click here to rapidly navigate through this document Exhibit 10.42 GENERAL RELEASE AND SEPARATION AGREEMENT This General Release and Separation Agreement (hereafter "Agreement") is entered into between Rich Christensen (the "Executive"), and ArthroCare Corporation (the "Company") (collectively referred to as the "Parties"), effective eight days after the Executive's signature (the "Ef
February 14, 2011	EX-99.1	FORWARD-LOOKING STATEMENTS QuickLinks - Click here to rapidly navigate through this document Exhibit 99.1 FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K for the year ended December 31, 2010 contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors
February 14, 2011	EX-21.1	SUBSIDIARIES OF THE REGISTRANT QuickLinks - Click here to rapidly navigate through this document Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Subsidiary State or Country of Incorporation or Organization ArthroCare (Australasia) Pty Ltd. f/k/a TiMax Surgical Pty Ltd. Australia ArthroCare (Deutschland) AG f/k/a ArthroCare (Deutschland) GmbH Germany ArthroCare (Hong Kong) Limited Hong Kong ARTHROCARE CANADA LIMITED Canada ArthroCar
February 14, 2011	EX-18.1	February 14, 2011 QuickLinks - Click here to rapidly navigate through this document Exhibit 18.1 February 14, 2011 Board of Directors ArthroCare Corporation 7500 Rialto Boulevard Building Two, Suite 100 Austin, TX 78735 Dear Directors: We are providing this letter to you for inclusion as an exhibit to your Form 10-K filing pursuant to Item 601 of Regulation S-K. We have audited the consolidated financial statements
February 14, 2011	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ARTHROCARE CORPORATION (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) (C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ARTHROCARE CORPORATION (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 043136100 (CUSIP Number) December 31, 2010 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu
February 10, 2011	EX-99.1	ARTHROCARE ANNOUNCES SETTLEMENT OF SEC INVESTIGATION NO FRAUD CHARGES OR PENALTY ASSESSED Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 The Ruth Group Nick Laudico / Zack Kubow 646-536-7030 / 7020 ARTHROCARE ANNOUNCES SETTLEMENT OF SEC INVESTIGATION NO FRAUD CHARGES OR PENALTY ASSESSED Austin, Texas ? February 9, 2011 ? ArthroCare Corp. (NASDAQ: ARTC) (the ?Company?) announced today that it has entered into a settlement with the United States
February 10, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2011 ARTHROCARE CORPO g UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2011 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File Number) (I.
December 14, 2010	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Numbe
December 6, 2010	POS AM	As filed with the Securities and Exchange Commission on December 6, 2010 POS AM 1 a2200800zposam.htm POS AM Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on December 6, 2010 Registration No. 333-166789 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ON FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ARTHROCARE C
December 2, 2010	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Numbe
November 18, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2010 ARTHROCARE CORP UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Numbe
November 3, 2010	S-8	As filed with the Securities and Exchange Commission on November 3, 2010 As filed with the Securities and Exchange Commission on November 3, 2010 Registration No.
November 1, 2010	424B3	5,805,921 Shares Common Stock par value $0.001 per share Filed Pursuant to Rule 424(b)(3) File No. 333-166789 PROSPECTUS SUPPLEMENT (To Prospectus dated August 6, 2010) 5,805,921 Shares Common Stock par value $0.001 per share This prospectus supplement supplements and amends the prospectus (the ?Prospectus?) dated August 6, 2010 filed with the Securities and Exchange Commission. The Prospectus and this prospectus supplement relate to the offer and sale
November 1, 2010	EX-99.1	ARTHROCARE REPORTS THIRD QUARTER 2010 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 The Ruth Group Nick Laudico / Zack Kubow 646-536-7030 / 7020 ARTHROCARE REPORTS THIRD QUARTER 2010 FINANCIAL RESULTS Austin, Texas ? November 1, 2010 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the third
November 1, 2010	EX-99.1	FORWARD-LOOKING STATEMENTS Exhibit 99.1 FORWARD-LOOKING STATEMENTS This quarterly report on Form 10-Q for the quarter ended September 30, 2010 contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors, the news media and others. Forward-looking statements oft
November 1, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422
November 1, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2010 ARTHROCARE CORPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
September 8, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2010 ARTHROCARE CORP UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Numbe
August 4, 2010	S-1/A	As filed with the Securities and Exchange Commission on August 4, 2010 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on August 4, 2010 Registration No.
August 3, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arthr
August 3, 2010	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction (Commission File Number) (I.R.S.
August 3, 2010	EX-99.1	ARTHROCARE REPORTS SECOND QUARTER 2010 FINANCIAL RESULTS Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 The Ruth Group Nick Laudico / Zack Kubow 646-536-7030 / 7020 ARTHROCARE REPORTS SECOND QUARTER 2010 FINANCIAL RESULTS Austin, Texas ? August 3, 2010 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the second
August 3, 2010	EX-99.2	CERTIFICATE OF CORRECTION FILED TO CORRECT CERTAIN ERRORS IN THE CERTIFICATE OF DESIGNATIONS OF SERIES A 3.00% CONVERTIBLE PREFERRED STOCK OF ARTHROCARE CORPORATION FILED IN THE OFFICE OF THE SECRETARY OF STATE OF THE STATE OF DELAWARE ON SEPTEMBER 1 Exhibit 99.2 CERTIFICATE OF CORRECTION FILED TO CORRECT CERTAIN ERRORS IN THE CERTIFICATE OF DESIGNATIONS OF SERIES A 3.00% CONVERTIBLE PREFERRED STOCK OF ARTHROCARE CORPORATION FILED IN THE OFFICE OF THE SECRETARY OF STATE OF THE STATE OF DELAWARE ON SEPTEMBER 1, 2009 ArthroCare Corporation, a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), DOES HER
August 3, 2010	EX-99.1	FORWARD-LOOKING STATEMENTS Exhibit 99.1 FORWARD-LOOKING STATEMENTS This quarterly report on Form 10-Q for the quarter ended June 30, 2010 contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors, the news media and others. Forward-looking statements often in
June 25, 2010	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission Fil
May 14, 2010	EX-99.	EX-99. Exhibit 99 Form 4 Joint Filer Information Date of Event Requiring Statement: May 12, 2010 Issuer Name and Ticker or Trading Symbol: ArthroCare Corporation, ARTC Designated Filer: OEP AC Holdings, LLC Other Joint Filers: One Equity Partners III, L.
May 14, 2010	DEL AM	ArthroCare Corporation 7500 Rialto Blvd., Building Two, Suite 100 Austin, Texas 78735 May 14, 2010 ArthroCare Corporation 7500 Rialto Blvd., Building Two, Suite 100 Austin, Texas 78735 May 14, 2010 VIA EDGAR Mary Beth Breslin Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E., Mailstop 3030 Washington, D.C. 20549 Re: ArthroCare Corporation / Registration Statement on Form S-1 (File No. 333-166789) Dear Ms. Breslin: Reference is made to the registration stateme
May 13, 2010	S-1	As filed with the Securities and Exchange Commission on May 13, 2010 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on May 13, 2010 Registration No.
May 13, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2010 ARTHROCARE CORPORATI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number) 94
May 5, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2010 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arth
May 5, 2010	EX-99.1	REVENUE PRODUCT MARGIN EXHIBIT 99.1 FOR IMMEDIATE RELEASE: CONTACTS: Corinne Ervin 512-391-3907 The Ruth Group Nick Laudico / Zack Kubow 646-536-7030 / 7020 ARTHROCARE REPORTS FIRST QUARTER 2010 FINANCIAL RESULTS Austin, Texas ? May 5, 2010 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31
May 5, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2010 ARTHROCARE CORPORATIO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission File
May 5, 2010	EX-99.1	FORWARD-LOOKING STATEMENTS Exhibit 99.1 FORWARD-LOOKING STATEMENTS This quarterly report on Form 10-Q for the quarter ended March 31, 2010 contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors, the news media and others. Forward-looking statements often i
May 4, 2010	DEFA14A	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defi
March 23, 2010	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame QuickLinks - Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 15, 2010	EX-99.1	REVENUE PRODUCT MARGIN EXHIBIT 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 The Ruth Group Nick Laudico / Zack Kubow 646-536-7030 / 7020 ARTHROCARE REPORTS FOURTH QUARTER AND ANNUAL 2009 FINANCIAL RESULTS Austin, Texas ? March 15, 2010 ? ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for
March 15, 2010	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 Commission File Number: 0-27422 ARTHROC Use these links to rapidly review the document TABLE OF CONTENTS ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 Commission File Number: 0-27422 ARTHROCARE CORPORATION
March 15, 2010	EX-21.1	SUBSIDIARIES OF THE REGISTRANT QuickLinks - Click here to rapidly navigate through this document Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Subsidiary State or Country of Incorporation or Organization ArthroCare (Australasia) Pty Ltd. f/k/a TiMax Surgical Pty Ltd. Australia ArthroCare (Deutschland) AG f/k/a ArthroCare (Deutschland) GmbH Germany ArthroCare (Hong Kong) Limited Hong Kong ARTHROCARE CANADA LIMITED Canada ArthroCar
March 15, 2010	EX-99.1	FORWARD-LOOKING STATEMENTS QuickLinks - Click here to rapidly navigate through this document Exhibit 99.1 FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K for the year ended December 31, 2009 contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors
March 15, 2010	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number)
March 4, 2010	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number) 9
February 23, 2010	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
February 16, 2010	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ARTHROCARE CORPORATION (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) (C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ARTHROCARE CORPORATION (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 043136100 (CUSIP Number) December 31, 2009 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu
February 8, 2010	EX-99.1	ArthroCare Receives Costa Rica Tax Holiday Extension EX-99.1 2 v173501ex99-1.htm Exhibit 99.1 ArthroCare Receives Costa Rica Tax Holiday Extension AUSTIN, Texas-(BUSINESS WIRE)—February 8, 2010 - ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today that the Costa Rican government has granted an extension of the Company’s current tax holiday. Under the holiday extension, the C
February 8, 2010	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 v1735018k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Co
January 19, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 19, 2010 ARTHROCARE CORPO UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 19, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number
January 19, 2010	EX-99.1	ArthroCare Shares to Begin Trading on NASDAQ Global Market Exhibit 99.1 ArthroCare Shares to Begin Trading on NASDAQ Global Market AUSTIN, Texas-(BUSINESS WIRE)?January 19, 2010 - ArthroCare Corp. (Pink Sheets: ARTC.PK), a leader in developing state-of-the-art, minimally invasive surgical products, announced today that The NASDAQ Stock Market LLC has approved its application for the listing of its common stock on the NASDAQ Global Market. The Company?s sh
January 19, 2010	8-A12B	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ARTHROCARE CORPORATION (Exact name of registr UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3180312 (State of incorporation or organization) (I.R.S. Employer Identification No.) 7500 Rialto Blvd.,
January 11, 2010	EX-10.1	2010 Executive Officer Bonus Plan Exhibit 10.1 2010 Executive Officer Bonus Plan Objective: - Align the interests of employees and shareholders in the future growth and success of ArthroCare Corporation (the ?Company?) by rewarding employee performance. Bonus Pool: - The officer bonus pool is equal to the sum of the target bonuses of all officers in the pool and are covered in this document during the period of January 1, 2010 thr
January 11, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2010 ARTHROCARE CORPOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2010 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Number)
December 23, 2009	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2009 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (Commission
December 21, 2009	EX-24.	EX-24. Exhibit 99 Form 3 Joint Filer Information Date of Event Requiring Statement: December 16, 2009 Issuer Name and Ticker or Trading Symbol: ArthroCare Corporation, ARTC Designated Filer: OEP AC Holdings, LLC Other Joint Filers: One Equity Partners III, L.
December 14, 2009	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 v1689328k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2009 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorpo
December 14, 2009	EX-10.1	2009 Executive Officer Bonus Plan Exhibit 10.1 2009 Executive Officer Bonus Plan Objective: - Align the interests of employees and shareholders in the future growth and success of ArthroCare Corporation (the ?Company?) by rewarding employee performance. Bonus Pool: - Up to 100% of the Total Bonus Potential of all Eligible Participants during the period of January 1, 2009 through December 31, 2009 (the ?Bonus Period?). The Total Bo
December 8, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2009 ARTHROCARE CORP UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2009 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of Incorporation) 0-027422 (Commission File Numbe
November 30, 2009	EX-99.1	JOINT FILING AGREEMENT EX-99.1 2 a5282779b.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf
November 30, 2009	SC 13G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ARTHROCARE CORPORATION (Name of Issuer) Common Stock, $0.001 Par Value (Title of Class of Securities) 043136100 (CUSIP Number) November 20, 2009 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua
November 24, 2009	EX-21.1	SUBSIDIARIES OF THE COMPANY Subsidiary State or Country of Incorporation or Organization ArthroCare (Australasia) Pty Ltd. f/k/a TiMax Surgical Pty Ltd. Australia ArthroCare (Deutschland) AG f/k/a ArthroCare (Deutschland) GmbH Germany ArthroCare (Hon Exhibit 21.1 SUBSIDIARIES OF THE COMPANY Subsidiary State or Country of Incorporation or Organization ArthroCare (Australasia) Pty Ltd. f/k/a TiMax Surgical Pty Ltd. Australia ArthroCare (Deutschland) AG f/k/a ArthroCare (Deutschland) GmbH Germany ArthroCare (Hong Kong) Limited Hong Kong ARTHROCARE CANADA LIMITED Canada ArthroCare Corporation Cayman Islands Cayman Islands ArthroCare Costa Rica, S.
November 24, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 24, 2009 ARTHROCARE CORP Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 24, 2009 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (C
November 24, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2009 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422
November 24, 2009	EX-99.1	FORWARD-LOOKING STATEMENTS Exhibit 99.1 FORWARD-LOOKING STATEMENTS This report contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors, the news media and others. Forward-looking statements often include words such as ?expects,? ?anticipates,? ?intends,? ?p
November 24, 2009	EX-99.1	ARTHROCARE ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2009 Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 Joele Frank, Wilkinson Brimmer Katcher Andrea Priest / Jennifer Friedman 212-355-4449 ARTHROCARE ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2009 Austin, Texas ? November 24, 2009 ? ArthroCare Corp. (Pink Sheets: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, an
November 20, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2009 ARTHROCARE CORP Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2009 ARTHROCARE CORPORATION (Exact name of registrant as specified in its charter) Delaware 0-027422 94-3180312 (State or other jurisdiction of Incorporation) (C
November 20, 2009	EX-99.1	ARTHROCARE FILES ITS SECOND QUARTER FORM 10-Q FOR 2009 Exhibit 99.1 FOR IMMEDIATE RELEASE: CONTACTS: ArthroCare Corp. Corinne Ervin 512-391-3907 Joele Frank, Wilkinson Brimmer Katcher Andrea Priest / Jennifer Friedman 212-355-4449 ARTHROCARE FILES ITS SECOND QUARTER FORM 10-Q FOR 2009 Austin, Texas ? November 19, 2009?ArthroCare Corp. (Pink Sheets: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced that it
November 19, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2009 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arthr
November 19, 2009	EX-99.1	FORWARD-LOOKING STATEMENTS EXHIBIT 99.1 FORWARD-LOOKING STATEMENTS This report contains forward-looking statements, which are statements about matters that are not historical or current facts. In addition, our management may from time to time make forward-looking statements orally to analysts, investors, the news media and others. Forward-looking statements often include words such as ?expects,? ?anticipates,? ?intends,? ?p
November 18, 2009	EX-10.1	CONFIDENTIAL ArthroCare Corporation Smith & Nephew, Inc. Pricing and Delivery Amendment 16 June 2008 EXHIBIT 10.1 CONFIDENTIAL ArthroCare Corporation And Smith & Nephew, Inc. Pricing and Delivery Amendment 16 June 2008 1. The Distribution Agreement between ArthroCare Corporation, and ArthroCare Corporation Cayman Islands (“ARTC”) and Smith & Nephew, Inc. (“S&N”) dated September 2, 2005 (the “Agreement”) It amended as follows. Except as expressly stated in this Pricing and Delivery Amendment 16 Ju
November 18, 2009	EX-10.2	CONFIDENTIAL ArthroCare Corporation and Smith & Nephew, Inc. Amendment 16 June 2008 for Development and Supply of S&N Branded Probes and Controllers EXHIBIT 10.2 CONFIDENTIAL ArthroCare Corporation and Smith & Nephew, Inc. Amendment 16 June 2008 for Development and Supply of S&N Branded Probes and Controllers The Supply and Distribution Agreement between ArthroCare Corporation and ArthroCare Corporation Cayman Islands (“ARTC”) and Smith & Nephew, Inc. (“S&N”) dated September 2, 2005 (the “Agreement”) is amended as follows. Except as expressly
November 18, 2009	EX-10.51	ARTHROCARE CORPORATION 7500 Rialto Boulevard Building Two, Suite 100 Austin, Texas 78735 August 14, 2009 EXHIBIT 10.51 ARTHROCARE CORPORATION 7500 Rialto Boulevard Building Two, Suite 100 Austin, Texas 78735 August 14, 2009 OEP AC Holdings, LLC 320 Park Avenue, 18th Floor New York, New York 10022 Re: Disclosure Letter Ladies and Gentlemen: Reference is made to the Securities Purchase Agreement (the ?Agreement?), entered into as of August 14, 2009, by and between ArthroCare Corporation, a Delaware cor
November 18, 2009	EX-10.53	ArthroCare Corporation 7500 Rialto Blvd., Building Two Suite 100 Austin, Texas 78735 September 1, 2009 EXHIBIT 10.53 EXECUTION VERSION ArthroCare Corporation 7500 Rialto Blvd., Building Two Suite 100 Austin, Texas 78735 September 1, 2009 OEP AC Holdings, LLC c/o One Equity Partners III, L.P. 320 Park Avenue, 18th Floor New York, New York 10022 Attn: Gregory A. Belinfanti and Christian Ahrens Greg and Chris: Reference is hereby made to the Securities Purchase Agreement dated as of August 14, 2009 (t
November 18, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2008 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422
November 18, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2008 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-27422 Arthr
November 18, 2009	EX-10.31	AMENDMENT TO SUPPLY AND DISTRIBUTION AGREEMENT EXHIBIT 10.31 AMENDMENT TO SUPPLY AND DISTRIBUTION AGREEMENT This Amendment by and between Smith & Nephew, Inc, (?SNN?), ArthroCare Corporation Cayman Islands and ArthroCare Corporation, (collectively ?ArthroCare?) effective as of September 20th, 2007 (the ?Effective Date?) is a modification to the Supply and Distribution Agreement entered as of September 2, 2005 by and between the same parties he

ARTC / Arthrocare Corp - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)